Arch Therapeutics's total assets for Q3 2024 were $1.40M, a decrease of -9.25% from the previous quarter. ARTH total liabilities were $13.96M for the fiscal quarter, a 12.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.